November 9, 2011 – Pediatric neuroscientists at Oregon Health & Science University Doernbecher Children’s Hospital are the first to use high-magnetic-field-strength magnetic resonance imaging (MRI) to reveal tiny white matter injuries in the developing brain previously undetectable using standard MRI.

Early, accurate identification of these lesions in the preterm human infant could prevent delays in therapy and enable physicians to inform families sooner of the potential for complications. The team’s findings are published in the Annals of Neurology.

White matter injury is the most common cause of chronic neurologic disability in children with cerebral palsy, explained principal investigator Stephen Back, M.D., Ph.D., but babies with cerebral palsy often have MRIs that miss injury, which creates significant challenges, including delayed treatment intervention and rehabilitation.

“Until now there hasn’t been a compelling reason to put preterm babies into a high-field MRI scanner. Our work indicates the magnetic field strength of current clinical MRI may be a limiting factor to detecting some white matter lesions in the preterm infant. Now that we can detect this injury, we also hope our findings may encourage MRI researchers to find more sensitive means to detect this injury with lower field MRIs that are widely available,” said Back, an associate professor of pediatrics and neurology in the Papé Family Pediatric Research Institute at OHSU Doernbecher Children’s Hospital.

High-field MRI scanners are still mostly used as a research tool and not widely available outside of specialized MRI research centers like OHSU, Back added.

White matter injury occurs during brain development when nerve fibers are actively being wrapped in myelin, the insulation that allows nerve fibers to rapidly transmit signals in the brain. The cells required to make myelin can be easily destroyed when blood flow to the developing brain falls below normal or when maternal infection occurs during pregnancy. The loss of these cells disrupts brain maturation and results in failure to make the myelin required for normal brain function.

Preterm infants are particularly susceptible to these injuries, which can result in lifelong impairments, including inability to walk as well as intellectual challenges.

In this study, using high-field MRI (12-Tesla), Back and colleagues were able to identify tiny brain lesions in preterm fetal sheep with characteristics previously unseen and unreported using a standard 3-T MRI. Prior to this study, progress to developing treatments for white matter injury in the preterm infant had been hampered by clinicians’ inability to see these microscopic injuries, and just one tiny lesion can have a tremendous impact on the patient’s ability to walk and learn.

“Our findings support the potential of using high-field MRI for early identification, improved diagnosis and prognosis of white matter injury in the preterm infant, and our large preclinical animal model provides unique experimental access to questions directed at the cause of these lesions, as well as the optimal field strength and modality to resolve evolving lesions using MRI,” said Back.

Future studies are needed to determine the clinical-translational utility of high-field MRI, Back added.

The study was funded by a Javits Award from the National Institute of Neurological Diseases and Stroke (NINDS), a branch of the National Institutes of Health; the American Heart Association; and the March of Dimes Birth Defects Foundation.

OHSU investigators who contributed to this study include: Art Riddle, Ph.D.; Justin Dean, Ph.D.; Joshua Buser; Xi Gong, M.D.; Jennifer Maire; Kevin Chen; Tahir Ahmad; Victor Cai; Thuan Nguyen, Ph.D.; Christopher D. Kroenke, Ph.D.; and A. Roger Hohimer, Ph.D.

For more information: Stephen Back Lab

 


Related Content

News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
Subscribe Now